Cardiovascular Involvement in Systemic Lupus Erythematosus: Focus on Arrhythmias
Diagnostics · 23.01.2026 · 16 (3) · 372
DOI: 10.3390/diagnostics16030372 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 23.01.2026. Verfasst von Monica Claudia Dobos und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences II, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cardiovascular implications in systemic lupus erythematosus (SLE) are common and varied, including impacts on the pericardium, myocardium, valves, coronary arteries, and conduction system; all of these could be potential substrates or triggers of cardiac arrhythmias by interfering with disease severity and specific medication. Therefore, this narrative review aimed to assess the cardiac involvement in SLE underlying, mainly, cardiac arrhythmias.
Methods
We analyzed studies, published between 2015 and 2025 on PubMed, which explore cardiovascular involvement with a focus on arrhythmias in SLE from the perspectives of epidemiology, underlying mechanisms, diagnostic techniques, and the impact of standard and biologic therapies.
Results
The cardiac manifestation of LES (lupus pericarditis, lupus myocarditis, Libman–Sacks endocarditis, coronary artery disease, coronary vasculitis or myocardial fibrosis) represents a substrate for arrhythmia risk. These substrates, in association with other arrhythmias mechanisms considered as triggers or conduction abnormalities, determined arrhythmogenic conditions in these patients. In addition to structural heart disease, arrhythmias in SLE are caused by ongoing inflammation, immune system irregularities, microvascular problems, autonomic imbalance, oxidative stress, and side effects from treatments. Despite this complex background, arrhythmias are often overlooked and not routinely investigated in SLE care. Data that show how disease-modifying drugs may affect arrhythmias are limited and inconsistent, highlighting significant gaps in knowledge. Cardiac arrhythmias are a significant but, as yet, insufficiently underrecognized aspect of SLE, with serious implications for prognosis.
Conclusions
Systemic lupus erythematosus causes cardiovascular involvement that is associated with arrhythmias through various and complexes mechanisms, mainly related to direct cardiovascular structural damage, systemic inflammation or specific therapies. Data on arrhythmias secondary to cardiovascular damage in patients with SLE in the literature are limited. Therefore, early detection of electrical issues, regular cardiovascular evaluation in high-risk patients, and careful management of treatment effects are vital. A coordinated, multidisciplinary cardio-rheumatology approach is essential to improving arrhythmia detection, tailoring treatments, and ultimately decreasing cardiovascular complications and deaths in SLE patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Sciences II, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
- Department of Rheumatology, Clinic Rehabilitation Hospital, 700661 Iasi, Romania.
- Department of Medical Sciences I, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
- Department of Internal Medicine, Sf. Spiridon County Clinical Emergency Hospital, 700111 Iasi, Romania.
- Department of Surgery, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
- Department of Internal Medicine and Gastroenterology, Carol Davila University of Medicine and Pharmacy, Central Military Emergency University Hospital, 010825 Bucharest, Romania.
ORCID-Profile: Veronica Ungurean, Mara Russu, Anca Ouatu, Paula Cristina Morariu, Alexandru Florinel Oancea, Daniela Maria Tanase, Codrina Ancuta, Mariana Floria
Zitieren
APA
Dobos, M. C., Ungurean, V., Costan, D. E., Russu, M., Ouatu, A., Morariu, P. C., Oancea, A. F., Godun, M. M., Floria, D. E., Marcu, D. T., Baroi, G. L., Stanciu, S. M., Knieling, A., Tanase, D. M., Ancuta, C., & Floria, M. (2026). Cardiovascular Involvement in Systemic Lupus Erythematosus: Focus on Arrhythmias. Diagnostics, 16(3), 372. https://doi.org/10.3390/diagnostics16030372
Vancouver
Dobos MC, Ungurean V, Costan DE, Russu M, Ouatu A, Morariu PC, et al. Cardiovascular Involvement in Systemic Lupus Erythematosus: Focus on Arrhythmias. Diagnostics. 2026;16(3):372. doi:10.3390/diagnostics16030372
BibTeX
@article{Dobos2026,
author = {Dobos, Monica Claudia and Ungurean, Veronica and Costan, Diana Elena and Russu, Mara and Ouatu, Anca and Morariu, Paula Cristina and Oancea, Alexandru Florinel and Godun, Maria Mihaela and Floria, Diana-Elena and Marcu, Dragos Traian and Baroi, Genoveva Livia and Stanciu, Silviu Marcel and Knieling, Anton and Tanase, Daniela Maria and Ancuta, Codrina and Floria, Mariana},
title = {Cardiovascular Involvement in Systemic Lupus Erythematosus: Focus on Arrhythmias},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {3},
pages = {372},
doi = {10.3390/diagnostics16030372}
}
EUVIMED